← Leaderboards
David J. Riese
Purdue University West Lafayette
$2,098,443
Attributed
$2,098,443
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $471.2K · FY2006–24$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,098,443 · 4
By mechanism
R01$1,213,268 · 1
R15$471,175 · 1
R21$414,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineMutantErbb4 GeneErbb2 GeneEpidermal Growth Factor ReceptorTumorSignal TransductionLigandsEpidermal Growth FactorTyrosine PhosphorylationBiological ModelsHeterodimerizationNeoplastic CellCouplingAutocrineBreastEpiregulinAgonistComplexDimerEpitheliumBiologicalAllyBinding (Molecular Function)
Grant awards (11)
Is ERBB4 a Driver of BRAF WT Melanomas?$450,826
R15 · FY2024 · CA · contact PI
Is ERBB4 a Driver of BRAF WT Melanomas?$20,349
R15 · FY2024 · CA · contact PI
Regulation of ErbB4 Signaling by Neuregulin Isoforms$181,463
R01 · FY2010 · CA · contact PI
Regulation of ErbB4 Signaling by Neuregulin Isoforms$57,264
R01 · FY2010 · CA · contact PI
Regulation of ErbB4 Signaling by Neuregulin Isoforms$238,664
R01 · FY2009 · CA · contact PI
Regulation of ErbB4 Signaling by Neuregulin Isoforms$238,603
R01 · FY2008 · CA · contact PI
Regulation of ErbB4 Signaling by Neuregulin Isoforms$238,542
R01 · FY2007 · CA · contact PI
Regulation of ErbB4 Signaling by Neuregulin Isoforms$258,732
R01 · FY2006 · CA · contact PI
Tumor Imaging Agents Directed Against ErbB2$150,000
R21 · FY2002 · CA
Tumor Imaging Agents Directed Against ErbB2$150,000
R21 · FY2001 · CA
TUMOR CELL LINE PROLIFERATION, MOTILITY AND INVASIVENESS$114,000
R21 · FY2000 · CA